LYTIR

Insider · SEC Form 4 · EVP and Chief Legal Officer

Liu Joy

In the 12 months to Nov 8, 2026, on the open market: sold $1.2M of VRTX. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.2M in total.May: Insider sales $469KJun: Insider sales $364KJul: Insider sales $416KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. VRTXSold: VERTEX PHARMACEUTICALS INC / MA Jul 1, 2026 828 shares filed Jul 6, 2026 19,131 shares held directly after, as filed 10b5-1 plan filing $416K
  2. VRTXSold: VERTEX PHARMACEUTICALS INC / MA Jun 1, 2026 828 shares filed Jun 3, 2026 19,959 shares held directly after, as filed 10b5-1 plan filing $364K
  3. VRTXSold: VERTEX PHARMACEUTICALS INC / MA May 1, 2026 1,104 shares filed May 5, 2026 20,729 shares held directly after, as filed 10b5-1 plan filing $469K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.